Cilostazol Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Cilostazol Tablets are vascular care medicines utilized for intermittent claudication management, peripheral arterial disease treatment, and improvement of blood circulation in patients with restricted lower limb blood flow conditions.

The formulation contains Cilostazol, a phosphodiesterase inhibitor with antiplatelet and vasodilatory activity that helps improve peripheral blood circulation and reduce walking discomfort associated with impaired vascular blood supply.

Genliva Wellness LLP develops these formulations as a Cilostazol Tablets Manufacturer in India, while also operating as a Peripheral Vascular Disease Medicine Exporter and Blood Circulation Tablets Supplier for cardiovascular healthcare providers and regulated international pharmaceutical markets.

Cilostazol Tablets are formulated for peripheral circulation management therapy.

Oral antiplatelet vascular formulation
Frequently utilized in circulation management
Supports peripheral blood flow improvement
Helps reduce vascular walking discomfort

This formulation is prescribed in vascular management therapies.

Treatment of intermittent claudication
Management of peripheral arterial disease
Administered in blood circulation therapies
Utilized in vascular care protocols

Cilostazol Tablets deliver vascular circulation support for peripheral blood flow management.

Valuable in intermittent claudication treatment
Frequently preferred in peripheral vascular care
Effective circulation improvement therapy support
Useful in lower limb vascular management
Convenient oral vascular therapy administration
Maintains reliable circulatory therapeutic performance